6. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S.
Gestational diabetes: should it be added to the syndrome of insulin
resistance? Diabetes Care. 1997;20(5):867-71.
7. Masri B, Morin N, Pedebernade L, Knibiehler B, Audigier Y. The
apelin receptor is coupled to Gi1 or Gi2 protein and is differentially
desensitized by apelin fragments. Journal of Biological Chemistry.
2006;281(27):18317-26.
8. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, .
Isolation and characterization of a novel endogenous peptide ligand
for the human APJ receptor Biochemical and Biophysical Research
Communications 1998;251(2):471-6.
9. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli
A. Apelin, a newly identified adipokine up-regulated by insulin and
obesity. Endocrinology. 2005;146(4):1764-71.
10. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H.. Changes and relations
of circulating visfatin, apelin, and resistin levels in normal, impaired
glucose tolerance, and type 2 diabetic subjects. Experimental
and Clinical Endocrinology & Diabetes. 2006;114(10):544-8.
11. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli
A. Apelin, a newly identified adipokine up-regulated by insulin and
obesity. Endocrinology. 2005;146(4):1764-71.
12. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida
JM, Garcia-Arnes J, Tinahones FJ. Apelin levels are increased in morbidly
obese subjects with type 2 diabetes mellitus. Obesity Surgery.
2009;19(11):1574-80.
13. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma
S, et al. Apelin, the natural ligand of the orphan receptor APJ, is
abundantly secreted in the colostrum. Biochimical Biophysica Acta
1999;1452(1):25-35.
14. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C,
Winborn KY, et al. Pharmacological and immunohistochemical characterization
of the APJ receptor and its endogenous ligand apelin.
Journal of Neurochemistry 2003;84(5):1162-72.
6. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S.
Gestational diabetes: should it be added to the syndrome of insulin
resistance? Diabetes Care. 1997;20(5):867-71.
7. Masri B, Morin N, Pedebernade L, Knibiehler B, Audigier Y. The
apelin receptor is coupled to Gi1 or Gi2 protein and is differentially
desensitized by apelin fragments. Journal of Biological Chemistry.
2006;281(27):18317-26.
8. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, .
Isolation and characterization of a novel endogenous peptide ligand
for the human APJ receptor Biochemical and Biophysical Research
Communications 1998;251(2):471-6.
9. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli
A. Apelin, a newly identified adipokine up-regulated by insulin and
obesity. Endocrinology. 2005;146(4):1764-71.
10. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H.. Changes and relations
of circulating visfatin, apelin, and resistin levels in normal, impaired
glucose tolerance, and type 2 diabetic subjects. Experimental
and Clinical Endocrinology & Diabetes. 2006;114(10):544-8.
11. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli
A. Apelin, a newly identified adipokine up-regulated by insulin and
obesity. Endocrinology. 2005;146(4):1764-71.
12. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida
JM, Garcia-Arnes J, Tinahones FJ. Apelin levels are increased in morbidly
obese subjects with type 2 diabetes mellitus. Obesity Surgery.
2009;19(11):1574-80.
13. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma
S, et al. Apelin, the natural ligand of the orphan receptor APJ, is
abundantly secreted in the colostrum. Biochimical Biophysica Acta
1999;1452(1):25-35.
14. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C,
Winborn KY, et al. Pharmacological and immunohistochemical characterization
of the APJ receptor and its endogenous ligand apelin.
Journal of Neurochemistry 2003;84(5):1162-72.
Cündübey, C. R., & Tayyar, A. (2017). GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi, 7(3), 58-66.
AMA
Cündübey CR, Tayyar A. GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi. Eylül 2017;7(3):58-66.
Chicago
Cündübey, Cevat Rıfat, ve Ahmet Tayyar. “GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus”. Bozok Tıp Dergisi 7, sy. 3 (Eylül 2017): 58-66.
EndNote
Cündübey CR, Tayyar A (01 Eylül 2017) GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi 7 3 58–66.
IEEE
C. R. Cündübey ve A. Tayyar, “GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus”, Bozok Tıp Dergisi, c. 7, sy. 3, ss. 58–66, 2017.
ISNAD
Cündübey, Cevat Rıfat - Tayyar, Ahmet. “GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus”. Bozok Tıp Dergisi 7/3 (Eylül 2017), 58-66.
JAMA
Cündübey CR, Tayyar A. GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi. 2017;7:58–66.
MLA
Cündübey, Cevat Rıfat ve Ahmet Tayyar. “GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus”. Bozok Tıp Dergisi, c. 7, sy. 3, 2017, ss. 58-66.
Vancouver
Cündübey CR, Tayyar A. GESTASYONEL DİYABETLİ GEBELERDE FETAL VE MATERNAL APELİN DÜZEYLERİ Maternal and Fetal Apelin Levels in Gestational Diabetes Mellitus. Bozok Tıp Dergisi. 2017;7(3):58-66.